Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-25 @ 8:54 PM
Study NCT ID:
NCT05266456
Status:
COMPLETED
Last Update Posted:
2024-04-18
First Post:
2022-02-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults
Sponsor:
Vaxcyte, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-23
First Submit QC Date:
None
Study First Post Date:
2022-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-01-07
Results First Submit QC Date:
None
Results First Post Date:
2024-04-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-25
Last Update Post Date:
2024-04-18
Last Update Post Date Type:
ACTUAL